A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorder
A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorder
复制标题
DOI:
10.1016/j.ejpn.2017.12.017
复制
发表时间:
2018-05-01
影响因子:
3.1
通讯作者:
Basel-Salmon, Lina
中科院分区:
文献类型:
--
作者:
Orenstein, Naama;Goldberg-Stern, Hadassa;Basel-Salmon, Lina
Background: Early-onset epileptic encephalopathy (EOEE) is a severe convulsive disorder with a poor developmental prognosis. Although it has been associated with mutations in a number of genes, the fact that there is a large proportion of patients who remain undiagnosed suggests that there are many more still-unknown genetic causes of EOEE. Achieving a genetic diagnosis is important for understanding the biological basis of the disease, with its implications for treatment and family planning.Methods: Whole-exome sequencing was performed in a family of Ashkenazi Jewish origin in which a male infant was diagnosed with EOEE. There was no family history of a similar neurologic disease. The patient had extreme hypotonia, neonatal hypothermia, choreiform movements, and vision impairment in addition to the convulsive disorder.Results: A de novo heterozygous missense mutation, c.1003A > C, p.Asn335His, was identified in a conserved domain of GABRA2. GABRA2 encodes the alpha 2 subunit of the GABA(A) receptor.Conclusions: In the context of previous reports of an association of de novo mutations in genes encoding different subunits of the GABA(A) receptor (GABRB1, GABRA1, GABRG2, GABRB3) with autosomal dominant epileptic disorders, we conclude that a de novo mutation in GABRA2 is likely to cause autosomal dominant EOEE accompanied by a movement disorder and vision impairment. (C) 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.